NHIQ · Nanthealth, Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|
| Revenue | $67.00M | $62.65M | $73.17M | $95.96M | $86.68M | $86.68M |
| Cost of Revenue | $28.84M | $27.81M | $29.23M | $38.42M | $44.27M | $41.52M |
| Gross Profit | $38.16M | $34.84M | $43.95M | $57.54M | $45.20M | $45.15M |
| R&D | $23.05M | $19.71M | $17.27M | $19.07M | $20.92M | $33.86M |
| SG&A | $62.50M | $52.09M | $48.53M | $61.04M | $70.76M | $74.98M |
| Total Operating Expenses | $89.49M | $75.74M | $70.21M | $88.31M | $95.90M | $113.05M |
| D&A | $15.99M | $15.72M | $16.77M | $22.36M | $22.36M | $28.05M |
| Operating Income | ($51.33M) | ($40.90M) | ($26.27M) | ($30.77M) | ($50.70M) | ($67.90M) |
| Interest Expense | - | - | - | - | - | - |
| Income Tax | ($317.0K) | $97.0K | $447.0K | ($112.0K) | ($3.67M) | ($2.20M) |
| Net Income | ($67.78M) | ($58.26M) | ($56.33M) | ($62.76M) | ($192.15M) | ($175.21M) |
| EPS - Basic | ($8.80) | ($0.51) | - | - | - | - |
| EPS - Diluted | ($8.80) | ($0.51) | - | - | - | - |
Balance Sheet
| Line item | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.76M | $29.08M | $22.79M | $5.24M | $18.30M | $61.66M |
| Accounts Receivable | $5.95M | - | - | - | $15.29M | $11.49M |
| Inventory | - | - | - | $798.0K | $496.0K | $839.0K |
| Accounts Payable | $10.41M | $3.20M | $5.12M | $3.95M | $1.65M | $3.16M |
| Current Assets | $12.59M | $39.41M | $30.59M | $37.91M | $39.44M | $81.89M |
| Total Assets | $159.55M | $197.83M | $200.29M | $266.49M | $286.34M | $449.19M |
| Current Liabilities | $35.63M | $27.95M | $124.76M | $57.50M | $36.54M | $35.86M |
| Long-term Debt | - | - | - | - | - | - |
| Total Liabilities | $384.94M | $359.82M | $311.69M | $323.62M | $283.51M | $255.89M |
| Stockholders' Equity | ($225.39M) | ($161.99M) | ($111.78M) | ($57.14M) | $2.83M | $193.30M |
| Retained Earnings | ($1.12B) | ($1.05B) | ($1.00B) | ($946.88M) | ($884.12M) | ($693.23M) |
Cash Flow
| Line item | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | ($32.26M) | ($27.69M) | ($16.85M) | ($8.77M) | ($29.63M) | ($81.15M) |
| Investing Cash Flow | ($6.47M) | ($5.64M) | $35.25M | ($4.29M) | ($10.48M) | ($12.28M) |
| Financing Cash Flow | $10.80M | $40.58M | ($555.0K) | ($32.0K) | ($2.16M) | ($5.33M) |
| CapEx | $6.47M | $5.08M | $5.67M | $4.59M | $10.55M | $13.64M |
| Free Cash Flow | ($38.73M) | ($32.77M) | ($22.53M) | ($13.36M) | ($40.18M) | ($94.78M) |
Ratios
| Metric | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 57.0% | 55.6% | 60.1% | 60.0% | 52.1% | 52.1% |
| Operating margin | -76.6% | -65.3% | -35.9% | -32.1% | -58.5% | -78.3% |
| EBITDA margin | -52.7% | -40.2% | -13.0% | -8.8% | -32.7% | -46.0% |
| Net margin | -101.2% | -93.0% | -77.0% | -65.4% | -221.7% | -202.1% |
| Free cash flow margin | -57.8% | -52.3% | -30.8% | -13.9% | -46.4% | -109.4% |
| FCF / Net income | 0.57 | 0.56 | 0.40 | 0.21 | 0.21 | 0.54 |
| R&D / Revenue | 34.4% | 31.5% | 23.6% | 19.9% | 24.1% | 39.1% |
| SG&A / Revenue | 93.3% | 83.1% | 66.3% | 63.6% | 81.6% | 86.5% |
| Effective tax rate | - | - | - | - | - | - |
| Return on assets | -42.5% | -29.4% | -28.1% | -23.6% | -67.1% | -39.0% |
| Return on equity | 30.1% | 36.0% | 50.4% | 109.8% | -6787.4% | -90.6% |
| Return on invested capital | - | - | - | - | - | - |
| Liquidity | ||||||
| Current ratio | 0.35 | 1.41 | 0.25 | 0.66 | 1.08 | 2.28 |
| Quick ratio | 0.35 | 1.41 | 0.25 | 0.65 | 1.07 | 2.26 |
| Cash ratio | 0.05 | 1.04 | 0.18 | 0.09 | 0.50 | 1.72 |
| Leverage | ||||||
| Debt / Equity | - | - | - | - | - | - |
| Debt / Assets | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - |
| Interest coverage | - | - | - | - | - | - |
| Equity multiplier | -0.71 | -1.22 | -1.79 | -4.66 | 101.14 | 2.32 |
| Liabilities / Assets | 2.41 | 1.82 | 1.56 | 1.21 | 0.99 | 0.57 |
| Efficiency | ||||||
| Asset turnover | 0.42 | 0.32 | 0.37 | 0.36 | 0.30 | 0.19 |
| Inventory turnover | - | - | - | 48.15 | 89.25 | 49.49 |
| Days sales outstanding | 32d | - | - | - | 64d | 48d |
| Days inventory outstanding | - | - | - | 8d | 4d | 7d |
| Days payable outstanding | 132d | 42d | 64d | 38d | 14d | 28d |
| Cash conversion cycle | - | - | - | - | 55d | 28d |
| Valuation | ||||||
| P / E | - | - | - | - | - | - |
| P / B | - | - | - | - | - | - |
| P / S | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - |
| Growth | ||||||
| Revenue growth (YoY) | 6.9% | -14.4% | -23.7% | 10.7% | 0.0% | -13.7% |
| Revenue CAGR (3y) | -11.3% | -10.3% | -5.5% | -1.5% | - | - |
| Revenue CAGR (5y) | -5.0% | -9.0% | - | - | - | - |
| Gross profit growth (YoY) | 9.5% | -20.7% | -23.6% | 27.3% | 0.1% | 61.0% |
| Operating income growth (YoY) | -25.5% | -55.7% | 14.6% | 39.3% | 25.3% | 58.0% |
| Net income growth (YoY) | -16.3% | -3.4% | 10.3% | 67.3% | -9.7% | 4.8% |
| EPS growth (YoY) | -1625.5% | - | - | - | - | - |
| EPS CAGR (3y) | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - |
| FCF growth (YoY) | -18.2% | -45.5% | -68.7% | 66.8% | 57.6% | -9.7% |
| FCF CAGR (5y) | - | - | - | - | - | - |
| Book value growth (YoY) | -39.1% | -44.9% | -95.6% | - | -98.5% | 198.3% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2021-12-31.
Product / service
$125.28M totalSoftware Related$62.63M · 50.0%
Software As AService$60.40M · 48.2%
Maintenance$1.72M · 1.4%
Professional Services$507.0K · 0.4%
Product And Service Other$23.0K · 0.0%
Stability scores
Altman Z′
FY 2022 · bankruptcy risk
-6.88
Distress
Private-firm variant - uses book equity instead of market cap. > 2.90 safe · 1.23-2.90 grey · < 1.23 distress.
Piotroski F-score
FY 2022 · 9-point quality
4/9
Neutral
- ✗Net income positive
- ✗Operating cash flow positive
- ✗ROA improved YoY
- ✓Cash flow > net income
- -Long-term debt decreased
- ✗Current ratio improved
- ✓No share dilution
- ✓Gross margin improved
- ✓Asset turnover improved
Peer comparison
Same SIC group: Services-Computer Processing & Data Preparation
Comparing NantHealth against the 5 most active filers in the same SIC group.